Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study.

Annemarie Lyng Lyng SvenssonHanne-Dorthe EmborgLars Erik Bartels Torkell J EllingsenThomas AdelstenRené CordtzLene DreyerNiels Obel

Published in: Annals of the rheumatic diseases (2023)

Patients with IRD have a risk of SARS-CoV-2, which nearly corresponds to the general population but had a substantial increased risk of hospitalisation with COVID-19, severe COVID-19, requiring assisted ventilation and COVID-19 leading to death, especially in patients with comorbidities.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
oxidative stress
drug induced
respiratory failure